Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Combining
vaccine therapy with interleukin-2 may be a more effective treatment for metastatic melanoma
of the eye.
PURPOSE: Phase II trial to study the effectiveness of vaccine therapy and interleukin-2 in
treating patients who have metastatic melanoma of the eye.